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Abstract:  Thy-1 expression may influence myofibroblast development.  Through the epithelial-mesenchymal transition
(EMT), injured renal epithelial cells undergo regression to the metanephric mesenchymal phenotype and then acquire a
myofibroblastic nature (expressing α-smooth muscle actin; α-SMA).  Because the metanephric blastema differentiates
into mesenchymal and renal epithelial cells, we investigated Thy-1 immunoexpression during nephrogenesis in F344 rats
in correlation with vimentin and α-SMA expressions.  Kidney samples were obtained from fetuses on gestation days 18
and 21, neonates on days 1-18 and adults at 6 weeks of age.  Mesangial cells in S-shaped bodies and immature and
mature glomeruli continuously expressed both Thy-1 and α-SMA during early nephrogenesis (fetuses and neonates on
days 1-9).  During early nephrogenesis, loosely-arranged blastemal cell-derived mesenchymal cells in the cortex and
medulla also exhibited Thy-1 and α-SMA, although the α-SMA expression was weaker than that of Thy-1.  Vimentin
expression coincided with that of Thy-1.  These findings indicate that the derivation of α-SMA-expressing
myofibroblastic cells may be related to mesangial or blastemal cells expressing both Thy-1 and α-SMA.  Interestingly,
there was a difference in Thy-1 expression between cortical and medullary tubulointerstitial cells from late nephrogenesis
(neonates on days 12-18) and those from adults in that the cortical cells reacted faintly or negatively to Thy-1, whereas
the medullary cells reacted strongly to Thy-1; additionally, bundle-arranged mesenchymal cells that were only observed
in the neonates on days 1-12 reacted strongly to α-SMA, but faintly to Thy-1.  Blastemal cell-derived mesenchymal cells
seem to alter the immunoexpressions of Thy-1 and α-SMA, depending on the conditions which they develop.  Thy-1
immunoexpression would be useful for investigation of reverse embryogenesis, which might occur in fibrotic kidneys.
(J Toxicol Pathol 2010; 23: 1–10)
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Introduction
Metanephric development begins with mutual
induction between the mesenchymal cells of the metanephric
blastema and epithelial cells of the ureteric bud.  After
induction, some blastemal cell-derived mesenchymal cells
form epithelial cells of the renal tubules and glomeruli
through mesenchymal-epithelial transition (MET); others
persist in the interstitium, maintaining the features of
mesenchymal cells1.  The blastemal cells have potential to
differentiate toward both epithelial and mesenchymal cells
during nephrogenesis.  In renal interstitial fibrosis, which has
been regarded as the common and ultimate pathway in
chronic renal diseases regardless of the etiology,
myofibroblasts play an important role by producing
excessive extracellular matrices such as collagens2, 3.  The
myofibroblasts have an intermediate nature between
fibroblasts and smooth muscle cells and are also called
contractile cells4.  Besides the pre-existing interstitial
fibroblasts, in the fibrotic kidney, it has been considered that
renal tubular epithelial cells may be a possible origin of
myofibroblasts3,5,6.  In the process known as the epithelial-
mesenchymal transition (EMT), mature epithelial cells
undergo regression to the metanephric mesenchymal
phenotype in response to injury and then acquire
myofibroblastic characteristics7–10.  This suggests that
reverse embryogenesis occurs in fibrotic kidneys.  However,
the relationship between blastemal cells and myofibroblasts
remains to be investigated.
Thy-1 (CD90) is a 25-37-kDa GPI-anchored cell
surface protein11.  Hematopoietic and mesenchymal stem
cells have been reported to react with the Thy-1 antibody
based on findings from immunohistochemistry12, 13.
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Additionally, Thy-1 is heterogeneously expressed in
fibroblastic cells; its expression may correlate with
myofibroblast differentiation in the uterus, lungs, skin, orbit
and cornea14–18.  Thy-1 immunohistochemistry appears to be
useful for exploration of the origin and nature of
myofibroblasts.  Although it is well known that glomerular
mesangial cells specifically express Thy-119, 20, the
distribution of mesenchymal cells expressing Thy-1 has not
yet been investigated during rat renal development.  The
myofibroblasts seen in renal fibrotic lesions are
characterized fundamentally by expressions of cytoskeletons
such as α-smooth muscle actin (α-SMA) and vimentin3, 4.  In
the present study, therefore, the detailed distribution of Thy-
1 expressing cells was investigated in developing kidney
tissues of rats obtained from fetuses, neonates and adults, in
correlation with cells expressing α-SMA and vimentin, by
immunohistochemistry.  The present study showed that
along with glomerular mesangial cells, blastemal cells
expressed Thy-1 and vimentin during early nephrogenesis;
the Thy-1-positive cells partly agreed with α-SMA-positive
cells.  There may be a close relationship between blastemal
cells and cells with myofibroblastic features.
Materials and Methods
Animals
The following experiments were conducted in full
compliance with our institutional guidelines for animal care.
Pregnant F344 rats were obtained from Charles River Japan
(Hino, Shiga, Japan).  They and their neonates after birth
were housed in an animal room at 22 ± 3°C with a 12 h light-
dark cycle and allowed free access to a standard commercial
diet (MF, Oriental Yeast Co, Ltd., Tokyo, Japan) and tap
water.  Animals were euthanized by exsanguination under
ether anesthesia, and kidney samples were obtained from
fetuses on gestation days (GDs) 18 and 21, neonates on days
1, 3, 6, 9, 12, 15 and 18, and adults at 6 weeks of age (n=3-6
at each examination point).  The adult rats at 6 weeks of age
were all male, and both sexes were used for fetuses and
neonates.
Histopathology and Immunohistochemistry
Renal tissues were fixed in 10% neutral buffered
formalin, embedded in paraffin, sectioned at 3-4 μm
thickness and stained with hematoxylin and eosin (HE) for
morphological observations.
For the immunohistochemical analyses, renal samples
were fixed in periodate-lysine-paraformaldehyde (PLP)
fixative, embedded in paraffin by the AMeX method (PLP-
AMeX method) and sectioned at 2-3 μm21.  The peroxidase-
labeled amino acid polymer method was used with the
following primary antibodies: anti-Thy-1 monoclonal
antibody (×100; Cedarlane Laboratories Limited,
Burlington, ON, Canada), anti-α-SMA monoclonal antibody
(×200; Dako, Corp., Carpinteria, CA, USA) and anti-
vimentin monoclonal antibody (×200; Dako).  For antigen
retrieval, deparaffinized sections for Thy-1 and vimentin
were pretreated with a microwave for 10 min, and sections
for α-SMA were incubated with 0.1% trypsin for 10 min at
37°C.  After pretreatment, sections were incubated with 3%
H2O2 for 10 min to quench endogenous peroxidase and then
with 5% skimmed milk in phosphate-buffered saline (PBS)
for 30 min; they were then incubated with each primary
antibody overnight at 4°C.  Next, incubation with a Histofine
Simple Stain MAX-PO Kit (Nichirei, Tokyo, Japan) as the
secondary antibody for monoclonal antibodies was
performed for 1 h.  Positive reactions were visualized with
3,3’-diaminobenzidine tetrahydrochloride (DAB, Vector
Laboratories, Burlingame, CA, USA).  Serial sections were
made for co-expression to Thy-1 and α-SMA or vimentin.
Non-immunized mouse serum in place of the primary
antibody served as negative controls.  Sections were
counterstained lightly with hematoxylin.
Evaluation
Based on the immunohistochemical reactivity to Thy-1,
α-SMA or vimentin in the glomeruli, cortex and medulla, the
degree was evaluated as follows: –, negative; ±, faintly
positive; +, moderately/strongly positive.
Results
Nephrogenesis
To confirm nephrogenesis in the rat samples used in
this study, we observed the histology in HE-stained sections.
In the cortical areas of the fetuses on GDs 18 (Fig. 1a) and
21, loosely-arranged blastemal cell-derived mesenchymal
cells were abundantly seen among developing renal tubules
and glomeruli formed through the MET; the developing
glomeruli consisted of round-, comma- and S-shaped bodies
(Fig. 1a, arrows) generated from vesicles on the part of the
condensed metanephric blastema around the tip of the
ureteric bud (Fig. 1a).  The mesenchymal cells were
gradually decreased with age after birth (neonates), and
instead, mature renal tubules and glomeruli became
predominant (Fig. 1b); in neonates on 18 days, renal tissues
were completely formed and had similar histologies to those
of the adult rats (Fig. 1c); mesenchymal cells were only
present in the tubulointerstitium of the completed kidney.
In the medullary areas of the fetuses on GDs 18 and 21
(Fig. 2a), loosely-arranged mesenchymal cells were seen
surrounding the branched epithelial ureteric tubules (Fig. 2a,
arrows); in the neonates on days 1–15, the loosely-arranged
mesenchymal cells gradually decreased.  In the neonates on
day 1, mesenchymal cells arranged parallel to each other and
perpendicular to the developing renal tubules appeared in the
cortic-medullary junction; these bundle-arranged
mesenchymal cells became predominant in the neonates on
days 3-12 (Fig. 2b, arrows) and then disappeared in the
neonates on days 15 and 18 and the adults at 6 weeks of age.
In the neonates on day 18, mature renal tubules and
collecting ducts were observed, and a small number of
mesenchymal cells were present in the tubulointerstitium
(Fig. 2c) in the medulla and around blood vessels in theYuasa, Izawa, Kuwamura et al. 3
cortico-medullary junction.  These histological observations
indicate that nephrogenesis finishes around 18 days of age in
rats.
Immunohistochemistry during nephrogenesis
We evaluated the immunoreactivity of mesenchymal
cells for Thy-1, α-SMA and vimentin in the glomeruli
Fig. 1. Cortical areas during rat nephrogenesis.  Loosely-arranged
mesenchymal cells are prominently seen among the
developing renal tubules, and there are round-, comma- and
S-shaped bodies (arrows) as well as immature glomeruli in
the fetus on gestation day (GD) 18 (a).  In conjunction with
nephrogenesis, the mesenchymal cells are decreased in
neonates on days 6 (b) and 18 (c).  HE stain.  Bar=50 μm.
Fig. 2. Medullary areas during nephrogenesis.  Loosely-arranged
mesenchymal cells are seen mainly around the branched
epithelial ureteric tubules (arrows) in the fetus on gestation
day 21 (a).  Mesenchymal cells arranged parallel to each other
and perpendicular to the developing renal tubules (arrows)
are present in the cortico-medullary junction of the neonate
on day 3 (b).  Mature renal tubules and tubulointerstitial cells
are seen in neonate on day 18 (c).  HE stain.  Bar=50 μm.4 Thy-1 Expression in Rat Nephrogenesis
(mesangial cells), cortex and medulla (Table 1).
Immunoreactivity for Thy-1
In the fetuses on GDs 18 (Figs. 3a and 3c) and 21 and
the neonates on days 1-18, a few spindle-shaped cells
reacting to Thy-1 were seen among the epithelial cells in the
S-shaped bodies (Figs. 3a and 3c, large arrows); mesangial
cells in the immature glomeruli, in which podocytes and
blood vessels were being formed; and in the mature
glomeruli, which reacted strongly to Thy-1 (+) (Figs. 3a and
3c, small arrows).  In the adults at 6 weeks of age, the
mesangial cells in all glomeruli showed a strong reaction to
Thy-1 (+) (Fig. 6a).
In the cortical areas, loosely-arranged mesenchymal
cells around the developing renal tubules and glomeruli in
the fetuses on GDs 18 (Figs. 3a and 3c, arrowheads) and 21
and the neonates on days 1 and 3 gave a strong positive
reaction to Thy-1 (+), as did interstitial mesenchymal cells
close to the developed renal tubules in the neonates on days
6 and 9; however, the reactivity of interstitial mesenchymal
cells to Thy-1 became faint in the neonates on days 12-18
(±), and Thy-1-positive cells were not seen in the cortex of
adults (–) (Fig. 6a, Table 1).
In the medullary areas, loosely-arranged mesenchymal
cells around the immature renal tubules and branching
ureteric buds (collecting ducts) in the fetuses on GDs 18
(Fig. 4a) and 21 and the neonates on day 1 were strongly
reactive to Thy-1 (+); interstitial mesenchymal cells around
the developed renal tubules and collecting ducts in the
neonates on days 3-18 (Fig. 5a and 5c, small arrows) and in
the adults at 6 weeks of age (Fig. 6c) also reacted to Thy-1
(+) (Table 1).  Interestingly, the bundle-arranged
mesenchymal cells seen mainly in the cortico-medullary
junction in the neonates on days 1 to 12 showed a faint
reaction to Thy-1 (±) (Figs. 5a and 5c, large arrows; Table 1).
As described above, in the cortex of the adults at 6
weeks of age, Thy-1 reacted only with glomerular mesangial
cells and perivascular cells around arterioles (inset in Fig. 6a,
arrow) (+), but did not react with tubulointerstitial cells (–)
(Fig. 6a); interestingly, Thy-1 strongly reacted with
tubulointerstitial cells in the medulla (+) (Fig. 6c, Table 1).
Immunoreactivity for vimentin
Mesangial cells in the S-shaped body (Fig. 3d, large
arrow) and immature (Fig. 3d, small arrow) and mature types
of glomeruli of the fetuses, neonates and adults consistently
showed a positive reaction to vimentin; the
immunoreactivity of the mesangial cells to vimentin was
similar to that for Thy-1 (Table 1).
Loosely-arranged mesenchymal cells in the cortical and
medullary areas in the fetuses (Fig. 3d, arrowhead), neonates
(Fig. 5d, small arrows) and adults showed a positive reaction
for vimentin, although the reactivity of the mesenchymal
cells in the cortex became faint in the neonates on days 12-
18 and in the adults at 6 weeks of age (Table 1); the reactivity
was generally in agreement with that for Thy-1 (Figs. 3c and
3d for the cortex of the fetus; Fig. 5c and 5d for the cortico-
medullary junction; Table 1).
Bundle-arranged mesenchymal cells in the neonates on
days 1-12 reacted faintly to vimentin (Fig. 5d, large arrow). 
Immunoreactivity for α-SMA
Mesangial cells in the S-shaped body and immature
type of glomeruli of the fetuses on GDs 18 (Fig. 3b, arrow)
and 21 and of the neonates on day 1 reacted strongly to α-
SMA; the reactivity was similar to that for Thy-1 (Figs. 3a
Table 1. Immunohistochemical Reactivity to Thy-1, α-Smooth Muscle Actin (α-SMA) and Vimentin During Rat Nephrogenesis
Gestation days Days after birth Adults
(fetuses) (neonates)
Cells Antibody to 18 21 1 3 6 9 12 15 18 6 weeks
M e s a n g i a l  c e l l s * T h y - 1 ++++++++++
α- S M A +++±±±±±±±
V i m e n t i n++++++++++
Mesenchymal cells Thy-1 + + + + + + ± ± ± –
    in the cortex ** α- S M A ±±±++++++–
V i m e n t i n++++++±±±±
M e s e n c h y m a l  c e l l s T h y - 1 ++++++++++
   in the medulla** α- S M A ±±±+±±––––
V i m e n t i n±+++++++++
Bundle-arranged mesenchymal Thy-1 ± ± ± ± ±
   cells in the cortico-medullary α- S M A +++++
    junction*** Vimentin ± ± ± ± ±
Immunoreactivity was evaluated as follows: –, negative; ±, faintly positive; +, more strongly positive.  *: Mesangial cells seen in the S-
shaped body and immature and mature types of glomeruli.  **: Mesenchymal cells loosely-arranged in the cortex and medulla in fetuses and
early stage neonates, and tubulointerstitial mesenchymal cells in late stage neonates and adults.  ***: The unique and preferential arrangement
was seen only in neonates on days 1-12.Yuasa, Izawa, Kuwamura et al. 5
Fig. 3. Immunohistochemical findings in cortical areas for Thy-1 (a, c), α-smooth muscle actin (α-SMA) (b), and vimentin (d) on GD 18.  Thy-
1-positive cells are seen in S-shaped bodies (a, c; large arrows) and mesangial cell in immature glomeruli (a, c; small arrows);
additionally, loosely-arranged mesenchymal cells in the cortex react to Thy-1 (a, c; arrowheads).  In serial sections (a, b; small arrows),
Thy-1-positive mesangial cells (a) also react to α-SMA (b); additionally, there are loosely-arranged mesenchymal cells faintly reacting to
α-SMA in the cortex (b, arrowheads).  In serial sections (c, d), the vimentin-positive mesangial cells seen in immature glomeruli (c, d;
small arrows) and loosely-arranged mesenchymal cells in the cortex (c, d; arrowheads) correspond to Thy-1-positive cells.
Immunohistochemistry, counterstained with hematoxylin.  Bar=50 μm.
Fig. 4. Immunohistochemical findings in medullary areas for Thy-1 (a) and α-SMA (b) in serial sections (a, b) on GD 18.  Loosely-arranged
mesenchymal cells mainly around developing renal tubules react strongly to Thy-1 (a, arrows), whereas these cells show a faint reaction
to α-SMA (b, arrows).  Immunohistochemistry, counterstained with hematoxylin.  Bar= 50 μm.
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Fig. 5.
Fig. 6.Yuasa, Izawa, Kuwamura et al. 7
and 3b).  However, the reactivity gradually decreased in the
mature glomeruli of the neonates on days 3-18 and in the
adults at 6 weeks of age (Fig. 6b); the reactivity was much
weaker than that for Thy-1 (Table 1).
In the cortical areas, the reactivity of loosely-arranged
mesenchymal cells to α-SMA in the fetuses on GDs 18 and
21 and the neonates on day 1 was faint (Fig. 3b, arrowheads).
On the other hand, the reactivity of the cells to Thy-1 was
strongly positive (Fig. 3a, arrowheads).  But
tubulointerstitial mesenchymal cells close to the developing
renal tubules and developed renal tubules in the neonates on
days 3-18 exhibited a strong reaction for α-SMA (Fig. 5b,
small arrows); in the neonates on days 3-9, the distribution of
the α-SMA-positive cells coincided with that of Thy-1-
positive cells (Fig. 5a and 5b, small arrows).  Interestingly,
no tubulointerstitial mesenchymal cells reacted to α-SMA in
the adults (Fig. 6b).  In the medullary areas of the fetuses on
GDs 18 and 21 and the neonates on days 1-9, except on day
3, the reactivity of loosely-arranged mesenchymal cells to α-
SMA was weaker than that for Thy-1 (Figs. 4a and 4b, Table
1), but the distribution of the cells reacting to Thy-1
appeared to correspond partly to that to α-SMA (Figs. 4a and
4b, arrows).  No interstitial mesenchymal cells reacting to α-
SMA were seen in the medulla in the neonates on days 12-18
or the adults at 6 weeks of age (Fig. 6d), although
perivascular mesenchymal cells reacted to α-SMA (Fig. 6d,
arrows).
Bundle-arranged mesenchymal cells in the cortico-
medullary junction in the neonates on days 1-12 reacted
strongly to α-SMA (Fig. 5b, large arrow), although these
cells showed a very faint reaction for Thy-1 (Figs. 5a and 5c,
large arrows) and vimentin (Fig. 5d, large arrow).  There was
a difference in the immunoreactivity of bundle-arranged
mesenchymal cells between Thy-1/vimentin (faint) and α-
SMA (strong; Table 1).
Discussion
Mesangial cells
Thy-1 expression in glomerular mesangial cells has
been well characterized19, 20; in particular, nephropathy
induced in rats or mice by anti-Thy-1 antibody
administration has been used to investigate the pathogenesis
of glomerulonephritis22.  The present study confirmed Thy-1
expression in the mesangial cells of mature glomeruli in
adults.  Developing glomeruli during nephrogenesis consist
of round-, comma- and S-shaped bodies and immature and
mature types of glomeruli1.  Mesangial cells in the immature
type of glomeruli seen in the fetuses and neonates reacted
strongly to Thy-1.  Additionally, spindle cells present in the
S-shaped body showed a reaction for Thy-1, however, there
were no cells showing a clear reaction for Thy-1 in the
round- and comma-shaped bodies.  These findings indicated
that mesangial cells started to be formed from the S-shaped
body in conjunction with Thy-1 expression; because
podocyte folding and vascularization began to be seen in the
S-shaped body stage, formation of mesangial cells may be
related to podocytes and endothelial cells23.  Here, we must
take into consideration the difference in immunoreactivity of
Thy-1 between rats and humans; human Thy-1 expression in
mesangial cells is lost with renal development24.  The
expression patterns of mesangial cells for vimentin were
similar to those for Thy-1 (Table 1), indicating the
mesenchymal nature of the mesangial cells.  Mesangial cells
in the S-shaped body and immature glomeruli in the fetuses
on GDs 18 and 21, as well as in the neonates on day 1,
reacted strongly to α-SMA, and the reactivity gradually
reduced until adulthood.  In glomerular injury, such as IgA
and anti-Thy-1 antibody nephropathy, mesangial cells have
been considered to undergo transdifferentiation into
myofibroblasts (expressing α-SMA), culminating in
glomerulosclerosis20, 25.  Because the Thy-1-reacting
mesangial cells during early nephrogenesis also expressed
α-SMA, transdifferentiation in glomerulosclerosis implies
that glomerular mesangial cells undergo regression, thus
showing the nature of immature mesangial cells.
Loosely-arranged mesenchymal cells in the cortex and
medulla
The present study showed that blastemal cell-derived
mesenchymal cells loosely-arranged in the cortex and
medulla reacted strongly to Thy-1 in the fetuses on GDs 18
and 21, as well as in the early stages in the neonates on days
1-9.  The continuous expression of Thy-1 in the cortical and
Fig. 5. Immunohistochemical  findings in the cortico-medullary  junction  for Thy-1  (a, c), α-SMA  (b) and v imentin  (d)  3  days after  birth
(neonate).  Thy-1-positive cells are seen around the developing renal tubules (a, small arrows); the positive cells correspond to cells
reacting to α-SMA (b, serial section to a; small arrows) and vimentin (d, serial section to c, small arrows).  Bundle-arranged mesenchymal
cells seen in the cortico-medullary junction show a positive reaction for α-SMA (b; large arrow), whereas they show a faint reaction for
Thy-1 (a, b; large arrows); in serial sections (a for Thy-1 and d for vimentin), bundle-arranged mesenchymal cells reacted faintly to Thy-1
(a; large arrow) and vimentin (d; large arrow), in contrast to the strong reaction for α-SMA in the mesenchymal cells (b; large arrow).
Immunohistochemistry, counterstained with hematoxylin.  Bar=50 μm.
Fig. 6. Immunohistochemical findings for Thy-1 (a, c) and α-SMA (b, d) in adults at 6 weeks of age.  In serial sections (a, b) of the cortex,
mesangial cells in mature glomeruli react strongly to Thy-1 (a) and faintly to α-SMA (b).  Tubulointerstitial cells in the cortex do not react
to Thy-1 (a), whereas interstitial cells in the medulla show a strong reaction to Thy-1 (c).  In serial sections (c, d) of the medulla, Thy-1-
positive tubulointerstitial cells (c) do not react to α-SMA (d); similarly, cortical tubulointerstitial cells are negative for α-SMA (b).
Spindle-shaped cells (so-called pericytes) surrounding arteriolae show a positive reaction for Thy-1 (inset in a; arrow) and α-SMA (d;
arrows).  Immunohistochemistry, counterstained with hematoxylin.  Bar=50 μm.8 Thy-1 Expression in Rat Nephrogenesis
medullary mesenchymal cells during early nephrogenesis
was similar to that of glomerular mesangial cells.
Additionally, the present study showed for the first time that
there was a difference in Thy-1 immunoexpression between
cortical and medullary interstitial cells of the late stage in
neonates and adults in that the immunoreactivity of
tubulointerstitial cells in the cortex for Thy-1 gradually
decreased in the late stage in the neonates on days 12-18 and
then was completely lost in the adults, whereas the reactivity
of medullary interstitial cells remained intensive in the
neonates on days 12-18 and in the adults (Table 1).
Previously, it has been reported that cortical interstitial
fibroblasts in adults might differ in nature from medullary
interstitial fibroblasts26.  The difference of Thy-1 expression
in the present study supports this previous notion.  It has
been reported that interstitial fibroblastic cells in the uterus,
orbit, lung and skin heterogeneously show Thy-114, 15, 17, 27.
Since Thy-1 expression is related to cytokine secretion,
response to cytokines and differentiation14-18, it is likely that
the difference in Thy-1 expression between cortical and
medullary tubulointerstitial cells reflects diversity in their
functions.
Thy-1 immunoexpression in loosely-arranged
mesenchymal cells in the cortex and medulla during
nephrogenesis coincided mostly with vimentin
immunoexpression.  Vimentin antibody is used to identify
mesenchymal cells28.  These findings indicate that Thy-1-
expressing cells are blastemal cell-derived mesenchymal
cells.  
Immunoexpression of α-SMA is a marker for
myofibroblasts, which have been considered to be derived
from pre-existing fibroblasts or undifferentiated
mesenchymal cells in fibrotic tissues8, 10, 29.  Although the α-
SMA immunoreactivity was weaker than the Thy-1
reactivity, the distribution of Thy-1-expressing
mesenchymal cells in the cortex and medulla in fetuses and
neonates on days 1-9 coincided partly with that of α-SMA-
reacting cells.  Furthermore, in the cortexes of the neonates
on days 12-18, some α-SMA-reacting mesenchymal cells
corresponded to Thy-1-positive cells.  These findings
indicated that α-SMA-expressing cells might have been
generated from Thy-1-positive blastemal cells.  Blastemal
cells have the capacity to differentiate into renal epithelial
cells and mesenchymal cells1.  In the fibrotic kidney, some
myofibroblasts arise from regressed tubular epithelial cells
through the EMT7-10.  Taken together, the α-SMA-
expressing myofibroblasts seen in the fibrotic kidney may be
derived from metanephric blastemal cells expressing both
Thy-1 and α-SMA.  However, no α-SMA-positive
interstitial cells were observed in the medullas of the
neonates on days 12-18 or in those the adults, irrespective of
retained Thy-1 expression.  It seems likely that Thy-1 and α-
SMA expressions are changeable depending on
microenvironmental conditions in neonate and adult
kidneys.  The expression patterns of Thy-1 and α-SMA in
fibrotic kidneys should be investigated to clarify the
relationship between myofibroblasts and blastemal cells in
more detail; additionally, the factors that influence Thy-1 or
α-SMA expression need to be clarified.
It is worth noting that spindle-shaped cells (so-called
pericytes) surrounding arteriolae in the adults reacted to both
Thy-1 and α-SMA17, 30.  Immature blastemal cell-derived
mesenchymal cells may be present in adults, suggesting
another possible origin of myofibroblasts31-33.
Bundle-arranged mesenchymal cells
In the present study, mesenchymal cells, arranged
parallel to each other and perpendicular to the tubular
basement, were found in the cortico-medullary junction;
these unique histological structures were only seen in the
neonates on days 1-12.  Although the reactivities were faint,
the cells reacted to Thy-1 and vimentin, indicating that they
were blastemal cell-derived mesenchymal cells.
Interestingly, the cells showed a strong reaction to α-SMA.
A similar histological arrangement of mesenchymal cells has
been observed in the unilateral ureteral obstruction rat
model34; the authors speculated that the preferential
arrangement might be caused by continuous mechanical
force against urine retention in the pelvis and renal tubules.
The myofibroblasts observed in myocardial infarction have
been reported to be formed in association with hemodynamic
stimulus35.  Because α-SMA is expressed in myofibroblasts
(so-called contractile cells)4, 36, the α-SMA expression of
bundle-arranged mesenchymal cells might be related to
increased contractility for formation of renal tubules during
rat nephrogenesis; under the increased contractility, α-SMA
expression might be increased and Thy-1 expression might
be reduced.  As mentioned above, it would be interesting to
investigate the altered expression of Thy-1 and α-SMA in
blastemal cell-derived cells and factors influencing the
alteration.
In conclusion, the present study showed that in addition
to glomerular mesangial cells, blastemal cell-derived
mesenchymal cells arranged loosely in the cortex and
medullas of fetuses and neonates expressed Thy-1.  Thy-1-
positive cells also reacted to vimentin, indicating their
mesenchymal nature.  In addition, the Thy-1-expression
pattern corresponded generally to α-SMA-positive cells,
particularly in the fetuses and early stage neonates.  These
findings support the EMT theory (reverse embryogenesis) in
fibrotic kidneys.  Furthermore, in adults, tubulointerstitial
cells (expressing Thy-1) in the medulla differed from
cortical interstitial cells (negative to Thy-1); the bundle-
arranged mesenchymal cells seen in the neonates reacted
strongly to α-SMA, but faintly to Thy-1.  Thy-1
immunoexpression has been used as a marker of
pluriopotential stem cells12, 37.  Blastemal cells have the
capacity to differentiate into renal epithelial cells and
mesenchymal cells.  In addition to the association of
myofibroblasts (expressing α-SMA in fibrotic kidney) with
blastemal cells (expressing both Thy-1 and α-SMA), it
would be interesting to investigate the bone-marrow stem
cell derivation of blastemal cells.Yuasa, Izawa, Kuwamura et al. 9
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